Satoshi Morita
About
Satoshi Morita is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Satoshi Morita has authored 754 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 345 papers in Oncology, 334 papers in Pulmonary and Respiratory Medicine and 147 papers in Surgery. Recurrent topics in Satoshi Morita's work include Gastric Cancer Management and Outcomes (150 papers), Colorectal Cancer Treatments and Studies (145 papers) and Lung Cancer Treatments and Mutations (115 papers). Satoshi Morita is often cited by papers focused on Gastric Cancer Management and Outcomes (150 papers), Colorectal Cancer Treatments and Studies (145 papers) and Lung Cancer Treatments and Mutations (115 papers). Satoshi Morita collaborates with scholars based in Japan, United States and South Korea. Satoshi Morita's co-authors include Masataka Taguri, Junichi Sakamoto, Yasuhiro Kodera, Akira Inoue, Kunihiko Kobayashi, Koichi Hagiwara, Akihiko Gemma, Masami Okamoto, Tadao Kotaka and Isamu Okamoto and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.
In The Last Decade
Satoshi Morita
721 papers receiving 17.6k citations
Hit Papers
Peers
Satoshi Morita
Yasuo Ohashi Japan
Valter Torri Italy
Yuko Kitagawa Japan
Sun Young Rha South Korea
Keitaro Matsuo Japan
Sandro Barni Italy
Winette T.A. van der Graaf Netherlands
Laurence H. Baker United States
John J. Crowley United States
Giuseppe Tonini Italy
Citations per year, relative to Satoshi Morita Satoshi Morita (= 1×)
peers
Yasuo Ohashi
Countries citing papers authored by Satoshi Morita
Since
Specialization
Citations
This map shows the geographic impact of Satoshi Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Morita more than expected).
Fields of papers citing papers by Satoshi Morita
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Satoshi Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Morita. The network helps show where Satoshi Morita may publish in the future.
Co-authorship network of co-authors of Satoshi Morita
This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Morita. A scholar is included among the top collaborators of Satoshi Morita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Morita. Satoshi Morita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nakanishi, Koki, Naotoshi Sugimoto, Yasuhiro Kodera, et al.. (2025). Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study. PubMed. 8. 100184–100184.
2.
Motoo, Yoshiharu, Kazunari Tominaga, Hidekazu Suzuki, et al.. (2024). Selection of best randomized controlled trials of Japanese Kampo medicines: Introduction of the trials and the hardships in their conduction. Traditional & Kampo Medicine. 12(1). 63–73.
3.
Hayashi, Yasuyuki, Hiroe Ohnishi, Keisuke Mizuno, et al.. (2024). Changes in the Proportion of Each Cell Type After hiPSC-Derived Airway Epithelia Transplantation. Cell Transplantation. 33. 4241285882–4241285882.
4.
Kobayashi, Shogo, Akira Tomokuni, Yutaka Takeda, et al.. (2024). Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group. Hepatology Research. 54(7). 667–677.
5.
Takeda, Kentaro, Yusuke Yamaguchi, Masataka Taguri, & Satoshi Morita. (2023). TITE‐gBOIN‐ET: Time‐to‐event generalized Bayesian optimal interval design to accelerate dose‐finding accounting for ordinal graded efficacy and toxicity outcomes. Biometrical Journal. 65(7). e2200265–e2200265.
6.
Yamanaka, Hiroki, Takashi Nakano, Tatsuya Ito, et al.. (2023). A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy. 24. 167–173.
7.
Iizuka, Yusuke, Masahiro Hiraoka, Masaki Kokubo, et al.. (2023). Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study. Clinical and Translational Radiation Oncology. 39. 100591–100591.
8.
Kita, Yuki, Katsuhiro Ito, Takeshi Sano, et al.. (2022). Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias. Cancer Science. 113(11). 3912–3921.
9.
Miyauchi, Eisaku, Satoshi Morita, Atsushi Nakamura, et al.. (2022). Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR. Journal of Clinical Oncology. 40(31). 3587–3592.
10.
Watanabe, Junichiro, et al.. (2022). Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: a multicenter retrospective study. BMC Cancer. 22(1). 31–31.
11.
Masuda, Norikazu, Tetsuhiro Yoshinami, Masahiko Ikeda, et al.. (2021). Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214. Cancers. 13(17). 4399–4399.
12.
Sakamoto, Katsunori, Goro Honda, Toru Beppu, et al.. (2020). Comprehensive data of 3525 patients newly diagnosed with colorectal liver metastasis between 2013 and 2014: 2nd report of a nationwide survey in Japan. Journal of Hepato-Biliary-Pancreatic Sciences. 27(8). 555–562.
13.
Hashimoto, Motomu, Hiroko Yamamoto, Masao Tanaka, et al.. (2018). Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology International. 38(9). 1679–1689.
14.
Sato, Nobuaki, Norikazu Masuda, Takashi Morimoto, et al.. (2018). Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study. Cancer Medicine. 7(7). 3044–3056.
15.
Koyama, Yukihide, Tomio Andoh, Yoshinori Kamiya, et al.. (2013). Bumetanide, an Inhibitor of Cation-chloride Cotransporter Isoform 1, Inhibits γ-Aminobutyric Acidergic Excitatory Actions and Enhances Sedative Actions of Midazolam in Neonatal Rats. Anesthesiology. 119(5). 1096–1108.
16.
Kawasaki, Satsuki, Shinobu Satoh, Osamu Hasegawa, et al.. (2011). Female Preponderance in the Discordant Association between Retinopathy and Nephropathy in Patients with Type 2 Diabetes Mellitus. International Journal of Clinical Medicine. 2(1). 13–17.
17.
Tsushima, Kenji, Shusuke Sone, Keisaku Fujimoto, et al.. (2010). Identification of Occult Parechymal Disease Such as Emphysema or Airway Disease Using Screening Computed Tomography. COPD Journal of Chronic Obstructive Pulmonary Disease. 7(2). 117–125.
18.
Yatsuya, Hiroshi, et al.. (2010). Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis. Journal of Epidemiology. 20(1). 70–76.
19.
Inoue, Akira, Kunihiko Kobayashi, Kazuhiro Usui, et al.. (2009). First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy. Journal of Clinical Oncology. 27(9). 1394–1400.
20.
Morita, Satoshi, et al.. (2007). HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia.. PubMed. 69(3-4). 157–65.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yasuo Ohashi Breakdown of academic impact, for papers by Valter Torri Breakdown of academic impact, for papers by Yuko Kitagawa Breakdown of academic impact, for papers by Sun Young Rha Breakdown of academic impact, for papers by Keitaro Matsuo Breakdown of academic impact, for papers by Sandro Barni Breakdown of academic impact, for papers by Winette T.A. van der Graaf Breakdown of academic impact, for papers by Laurence H. Baker Breakdown of academic impact, for papers by John J. Crowley Breakdown of academic impact, for papers by Giuseppe Tonini